Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Instaflex Advanced
Can this joint supplement back up its stiff promises?
Renewal by Andersen’s ‘Made in USA’ Window Dressing
TINA.org files FTC complaint against company.
Ariat’s WorkHog Patriot Boots
Don’t let the American flags fool you.
NuBest Height Growth Supplements for Kids and Teens
Can supplements really help your child reach new heights?
Monetizing Minors
How brands exploit kid influencers and their followers.